Related references
Note: Only part of the references are listed.Novel staging system using carbohydrate antigen (CA) 19-9 in extrahepatic cholangiocarcinoma and its implications on overall survival
Sri Harsha Tella et al.
EJSO (2020)
Combination of serum gamma-glutamyltransferase and alkaline phosphatase in predicting the diagnosis of asymptomatic choledocholithiasis secondary to cholecystolithiasis
Yong Mei et al.
WORLD JOURNAL OF CLINICAL CASES (2019)
Prognostic relevance of preoperative bilirubin-adjusted serum carbohydrate antigen 19-9 in a multicenter subset analysis of 179 patients with distal cholangiocarcinoma
Louisa Bolm et al.
HPB (2019)
Serum gamma-glutamyltransferase and the overall survival of metastatic pancreatic cancer
Yuanyuan Xiao et al.
BMC CANCER (2019)
Approaches and Outcomes to Distal Cholangiocarcinoma
Rachel M. Lee et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2019)
Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study
Marin Strijker et al.
ACTA ONCOLOGICA (2019)
Serum levels of gamma-glutamyltransferase predict outcome in heart failure with preserved ejection fraction
Daniel Dalos et al.
SCIENTIFIC REPORTS (2019)
Usefulness of Carbohydrate Antigen 19-9 Test in Healthy People and Necessity of Medical Follow-up in Individuals with Elevated Carbohydrate Antigen 19-9 Level
Sang Pyo Lee et al.
KOREAN JOURNAL OF FAMILY MEDICINE (2019)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
The survival outcome and prognostic factors for distal cholangiocarcinoma following surgical resection: a meta-analysis for the 5-year survival
U. F. Wellner et al.
SURGERY TODAY (2017)
Gamma-glutamyltransferase and risk of chronic kidney disease: A prospective cohort study
Setor K. Kunutsor et al.
CLINICA CHIMICA ACTA (2017)
Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysis
John R. Bergquist et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database Study
John R. Bergquist et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2016)
Elevated Preoperative Serum Gamma-glutamyltranspeptidase Predicts Poor Prognosis for Hepatocellular Carcinoma after Liver Transplantation
Shun-Jun Fu et al.
SCIENTIFIC REPORTS (2016)
Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up
Stefano Andrianello et al.
LANGENBECKS ARCHIVES OF SURGERY (2015)
Serum tumor markers in bile duct cancer - a review
M. Grunnet et al.
BIOMARKERS (2014)
Distal Cholangiocarcinonna
Neha Lad et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2014)
Adjusting CA19-9 values to predict malignancy in obstructive jaundice: Influence of bilirubin and C-reactive protein
Gaetano La Greca et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Modulation of cell growth and cisplatin sensitivity by membrane γ-glutamyltransferase in melanoma cells
Maria Franzini et al.
EUROPEAN JOURNAL OF CANCER (2006)
Expression of γ-glutamyltransferase in cancer cells and its significance in drug resistance
A Pompella et al.
BIOCHEMICAL PHARMACOLOGY (2006)
gamma-Glutamyl transpeptidase overexpression increases metastatic growth of B16 melanoma cells in the mouse liver
E Obrador et al.
HEPATOLOGY (2002)
Share Paper
